v3.25.1
Note to the cash flow statement (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Adjustment for non-cash transactions      
Depreciation and impairment. € 45,499 € 43,642 € 65,566
Share-based compensation expenses 19,886 56,718 88,506
Increase/decrease (-) in retirement benefit obligations and provisions (524) 11 136
Unrealized exchange losses/gains (-) and non-cash other financial result (23,858) 19,908 (41,970)
Discounting effect of non-current deferred income (227) (645) 7,672
Discounting effect of other non-current liabilities (395) (318) 2,271
Discounting effect of contingent consideration receivable (4,002)    
Fair value re-measurement of warrants (4) (18) (186)
Net change in fair value of current financial investments (49,984) (22,690) (6,929)
Fair value adjustment financial assets held at fair value through profit or loss   390  
Fair value adjustment contingent consideration receivable (931)    
Other non-cash expenses (12) 2,292 2,229
Impairment loss on trade receivables 9,643    
Total adjustment for non-cash transactions (4,909) 99,291 117,296
Interest expense 912 1,867 6,967
Interest Income 89,378 79,319 14,344
Tax expense (1,705) 11,689 2,844
Correction for cash used for other liabilities related to the disposal of subsidiaries. 527    
Total adjustment for items to disclose separately under operating cash flow (89,644) (65,763) (4,533)
Gain on disposal of subsidiaries (52,488)    
Gain (-)/loss on sale of fixed assets 8 (1,091) (23)
Investment Income related to current financial investments (23,759) (15,597) (3,766)
Total adjustment for items to disclose separately under investing and financing cash flow (76,239) (16,688) (3,789)
Increase in inventories 23,039 (24,076) (34,588)
Increase (-)/ decrease in receivables (31,055) (39,114) 68,984
Increase/decrease (-) in liabilities (53,429) 31,817 (2,083)
Total change in working capital other than deferred income € (61,445) € (31,373) € 32,313